Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity
Background Vitiligo is an acquired cutaneous depigmenting disease caused by a T helper (Th) 1–cytotoxic T cells driven autoimmune attack against melanocytes, in which Th17 is also involved. Interleukin (IL)‐38 belongs to the IL‐1 family of cytokines and suppresses Th1 and Th17 activation. IL‐38 prot...
Saved in:
Published in | Journal of cosmetic dermatology Vol. 21; no. 8; pp. 3515 - 3521 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Vitiligo is an acquired cutaneous depigmenting disease caused by a T helper (Th) 1–cytotoxic T cells driven autoimmune attack against melanocytes, in which Th17 is also involved. Interleukin (IL)‐38 belongs to the IL‐1 family of cytokines and suppresses Th1 and Th17 activation. IL‐38 protein and mRNA levels have been found to be elevated in various autoimmune disorders and correlated with disease severity and activity, including psoriasis, systemic sclerosis, rheumatoid arthritis, and atopic dermatitis. No previous studies have been performed to investigate the expression of IL‐38 in patients with vitiligo.
Aim
To evaluate IL‐38 serum level in patients with vitiligo compared to healthy controls (Hcs) and examine the association between IL‐38 level and severity and activity of vitiligo.
Patients and Methods
The study comprised 21 patients with vitiligo and 21 Hcs. Vitiligo severity and activity were evaluated via Vitiligo Extent Score (VES) and Vitiligo Disease Activity (VIDA) Score, respectively. IL‐38 serum level was evaluated by enzyme‐linked immunosorbent assay.
Results
Vitiligo patients had significantly higher serum level of IL‐38 than Hcs (p < 0.001). This level was significantly higher among patients with signs of vitiligo activity (p = 0.048), correlated positively with VES (p < 0.001), and correlated negatively with the age of patients (p = 0.001) and the age of disease onset (p = 0.022).
Conclusion
IL‐38 serum level was higher in patients with vitiligo than in Hcs and was related to vitiligo severity and signs of activity. |
---|---|
Bibliography: | Funding information This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1473-2130 1473-2165 1473-2165 |
DOI: | 10.1111/jocd.14612 |